The increased serum PGRN levels were observed in different diseases, which are characterized by the presence of chronic low-grade inflammation (i.e., meta-inflammation), like atherosclerosis [17], neurodegenerative diseases [18], breast cancer [19], diabetes mellitus [20], as well as metabolic syndrome [21]. Here, GRN is linked to atherosclerosis.